|
- HIV and AIDS - World Health Organization (WHO)
WHO fact sheet on HIV and AIDS with key facts and information on signs and symptoms, transmission, risk factors, testing and counselling, prevention, treatment and WHO response
- HIV - Global - World Health Organization (WHO)
HIV is fully preventable Effective antiretroviral treatment (ART) prevents HIV transmission from mother to child during pregnancy, delivery and breastfeeding Someone who is on antiretroviral therapy and virally suppressed will not pass HIV to their sexual partners Condoms prevent HIV and other sexually transmitted infections, and prophylaxis use antiretroviral medicines to prevent HIV Male
- HIV - World Health Organization (WHO)
Since the beginning of the epidemic, 91 4 million [73 4–116 4 million] people have been infected with the HIV virus and about 44 1 million [37 6–53 4 million] people have died from HIV-related causes Globally, 40 8 million [37 0–45 6 million] people were living with HIV at the end of 2024 An estimated 0 7% [0 6-0 8%] of adults aged 15–49 years worldwide are living with HIV, although
- HIV and AIDS - World Health Organization (WHO)
For people living with HIV who are not diagnosed or taking ART, signs of HIV-related illness may develop within 5–10 years, although it can be sooner The time between HIV transmission and an AIDS diagnosis is usually 10-15 years, but sometimes longer There is a very small number of people who have managed to control the HIV infection without ART and are called ‘elite-controllers’ This
- 艾滋病毒和艾滋病 - World Health Organization (WHO)
概述 人类免疫缺陷病毒（艾滋病毒）是一种攻击人体免疫系统的感染。获得性免疫缺陷综合症（艾滋病）是该疾病的最晚期。 艾滋病毒以人体的白细胞为目标，削弱免疫系统。这使得感染者更容易患上肺结核、感染和某些癌症等疾病。 艾滋病毒经由感染者的体液传播，包括血液、母乳、精液和阴道
- HIV - World Health Organization (WHO)
HIV remains one of the world's most significant public health challenges, particularly in low- and middle-income countries As a result of advances in access to antiretroviral therapy (ART), HIV-positive people now live longer and healthier lives In addition, it has been confirmed that ART prevents onward transmission of HIV
- WHO recommends injectable lenacapavir for HIV prevention
The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice a year as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention, in a landmark policy action that could help reshape the global HIV response
- World AIDS Day 2024 - World Health Organization (WHO)
On 1 December WHO joins partners and communities to commemorate World AIDS Day 2024 Under the theme “Take the rights path: My health, my right!”, WHO is calling on global leaders and citizens to champion the right to health by addressing the inequalities that hinder progress in ending AIDS
|
|
|